Socioeconomic status and cervical cancer survival among older women: Findings from the SEER-Medicare linked data cohorts

Gynecologic Oncology

Volumn 102, Issue 2, 2006, Pages 278-284

  Coker, Ann L ^a   Du, Xianglin L ^a   Fang, Shenying ^a   Eggleston, Katherine S ^a  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cervical neoplasia; Co morbid conditions; Elderly; Medicare; Race; Socioeconomic status; Survival; Treatment

Indexed keywords

ACADEMIC ACHIEVEMENT; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CELL TYPE; COMORBIDITY; COMPARATIVE STUDY; ETHNOLOGY; FEMALE; HAZARD ASSESSMENT; HUMAN; HYSTERECTOMY; INCOME; MAJOR CLINICAL STUDY; POPULATION RESEARCH; POVERTY; PREDICTION; PRIORITY JOURNAL; RACE; SOCIOECONOMICS; SURVIVAL RATE; SURVIVAL TIME; UTERINE CERVIX CANCER;

AGED; AGED, 80 AND OVER; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MEDICARE; PROPORTIONAL HAZARDS MODELS; SEER PROGRAM; SOCIAL CLASS; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 33645885945     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.12.016     Document Type: Article

References (61)

1. Freeman H. Cancer in the socioeconomically disadvantaged. CA Cancer J. Clin. 39 (1989) 266-288
2. Ward E., Jemal A., Cokkinides V., Singh G.K., Cardinez C., Ghafoor A., et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J. Clin. 54 (2004) 78-93
3. Howell E.A., Chen Y.T., and Concato J. Differences in cervical cancer mortality among black and white women. Obstet. Gynecol. 94 (1999) 509-515
4. Samelson E.J., Speers M.A., Ferguson R., and Bennett C. Racial differences in cervical cancer mortality in Chicago. Am. J. Public Health 84 (1994) 1007-1009
5. Liu T., Wang X., Waterbor J.W., Weiss H.L., and Soong S.J. Relationships between socioeconomic status and race-specific cervical cancer incidence in the United States, 1973-1992. J. Health Care Poor Underserved 9 (1998) 420-432
6. Bradley C.J., Given C.W., and Roberts C. Health care disparities and cervical cancer. Am. J. Public Health 94 (2004) 2098-2103
7. Funch D.P. Socioeconomic status and survival for breast and cervical cancer. Women Health 11 (1986) 37-54
8. Newmann S.J., and Garner E.O. Social inequities along the cervical cancer continuum: a structured review. Cancer Causes Control 16 (2005) 63-70
9. Krieger N. Defining and investigating social disparities in cancer: critical issues. Cancer Causes Control 16 (2005) 5-14
10. Parikh S., Brennan P., and Boffetta P. Meta-analysis of social inequality and the risk of cervical cancer. Int. J. Cancer 105 (2003) 687-691
11. Jones W.B., Shingleton H.M., Russell A., Chmiel J.S., Fremgen A.M., Clive R.E., et al. Patterns of care for invasive cervical cancer. Results of a national survey 1984-1990. Cancer 76 (1995) 1934-1947
12. Greenwald H.P., Borgatta E.F., McCorkle R., and Polissar N. Explaining reduced cancer survival among the disadvantaged. Milbank Q. 74 (1996) 215-238
13. Brewster W.R. Young age as a prognostic factor in cervical cancer: results of a population-based study. Am. J. Obstet. Gynecol. 180 (1999) 1464-1467
14. Brooks S.E., Baquet C.R., Gardner J.F., Moses G., and Ghosh A. Cervical cancer-the impact of clinical presentation, health and race on survival. J. Assoc. Acad. Minor. Phys. 11 (2000) 55-59
15. Shelton D., Paturzo D., Flannery J., and Gregorio D. Race, stage of disease, and survival with cervical cancer. Ethn. Dis. 2 (1992) 47-54
16. Thoms W.W., Unger E.J., Johnson P.R., Spann C.O., Hunter S.H., Smith R., et al. Cervical cancer survival in a high risk urban population. Cancer 76 (1995) 2518-2523
17. Mundt A.J., Connell P.P., Campbell T., Hwang J.H., Rotmensch J., and Waggoner S. Race and clinical outcome in patients with carcinoma of the uterine cervix treated with radiation therapy. Gynecol. Oncol. 7 (1998) 151-158
18. Morgan M.A., Behbakht K., Benjamin I., Berlin M., King S.A., and Rubin S.C. Racial differences in survival from gynecologic cancer. Obstet. Gynecol. 88 (1996) 914-918
19. Farley J.H., Hines J.F., Taylor R.R., Carlson J.W., Parker M.F., Kost E.R., et al. Equal care ensures equal survival for African-American women with cervical carcinoma. Cancer 91 (2001) 869-873
20. Grigsby P.W., Hall-Daniels L., Baker S., and Perez C.A. Comparison of clinical outcome in black and white women treated with radiotherapy for cervical carcinoma. Gynecologic Oncology 79 (2000) 357-361
21. Ragland K.E., Selvin S., and Merrill D.W. Black-white differences in stage-specific cancer survival: analysis of seven selected sites. Am. J. Epidemiol. 133 (1991) 672-682
22. Schorge J.O., Lea J.S., Garner E.O., Rushka L.R., Miller D.S., and Coleman R.L. Cervical adenocarcinoma survival among Hispanic and white women: a multicenter cohort study. Am. J. Obstet. Gynecol. 188 (2003) 640-644
23. Singh G.K., Miller B.A., Hankey B.F., and Edwards B.K. Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975-2000. Cancer 101 (2004) 1051-1057
24. Eggleston K., Coker A., Williams M., Tortolero-Luna G., Martin J., and Tortolero S. Ethnicity, poverty, rural residence and cervical cancer survival in Texas, 1995-2000. American Journal of Epidemiology 1161 (2005) [174, Abstract]
25. Johnson M.G. Socioeconomic Differences in Cervical Cancer Survival among South Carolina Women (2003), University of South Carolina, Columbia, South Carolina
26. Murphy M., Goldblatt P., Thornton-Jones H., and Silcocks P. Survival among women with cancer of the uterine cervix: influence of marital status and social class. J. Epidemiol. Community Health 44 (1990) 293-296
27. Meanwell C.A., Kelly K.A., Wilson S., Roginski C., Woodman C., Griffiths R., et al. Young age as a prognostic factor in cervical cancer: analysis of population based data from 10,022 cases. Br. Med. J. 296 (1988) 386-391
28. Wright J.D., Gibb R.K., Geevarghese S., Powell M.A., Herzog T.J., Mutch D.G., et al. Cervical carcinoma in the elderly. Cancer 103 (2004) 85-91
29. Chapman G.W. Survival of advanced age females with cervical carcinoma. Gynecol. Oncol. 46 (1992) 287-291
30. Brun J.L., Stoven-Camou D., Trouette R., Lopez M., Chene G., and Hocke C. Survival and prognosis of women with invasive cervical cancer according to age. Gynecol. Oncol. 91 (2003) 395-401
31. Kosary C.L. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva and vagina. Semin. Surg. Oncol. 10 (1994) 31-46
32. Russell J.M., Blair V., and Hunter R.D. Cervical carcinoma: prognosis in younger patients. Br. Med. J. 295 (1987) 300-303
33. Spanos W.J., King A., Keeney E., Wagner R., and Slater J.M. Age as a prognostic factor in carcinoma of the cervix. Gynecol. Oncol. 35 (1989) 66-68
34. de Rijke J.M., van der Putten H.W., Lutgens L.C., Voogd A.C., Kruitwagen R.F., van Dijck J.A., et al. Age-specific differences in treatment and survival of patients with cervical cancer in the southeast of The Netherlands. Eur. J. Cancer 38 (2002) 2017-2041
35. Sawaya G.F., Sung H.Y., Kearney K.A., Miller M., W K., Hiatt R.A., et al. Advancing age and cervical cancer screening and prognosis. J. Am. Geriatr. Soc. 49 (2001) 1499-1504
36. Serur E., Fruchter R.G., Maiman M., McGuire J., Arrastia C.D., and Gibbon D. Age, substance abuse, and survival of patients with cervical carcinoma. Cancer 75 10 (1995) 2530-2538
37. Minagawa Y., Kigawa J., Itamochi H., and Terakawa N. The outcome of radiation therapy in elderly patients with advanced cervical cancer. Int. J. Gynaecol. Obstet. 58 (1997) 305-309
38. Prempree T., Patanaphan V., Sewchand W., and Scott R.M. The influence of patients' age and tumor grade on the prognosis of carcinoma of the cervix. Cancer 51 (1983) 1464-1771
39. Delaloye J.F., Pampallaona S., Coucke P.A., and De Grandi P. Younger age as a bad prognostic factor in patients with carcinoma of the cervix. Eur. J. Obstet. Gynecol. Reprod. Biol. 64 (1996) 201-205
40. Leveque J., Laurent J.F., Burtin F., Foucher F., Goyat F., Grall J.Y., et al. Prognostic factors of the uterine cervix adenocarcinoma. Eur. J. Obstet. Gynecol. Reprod. Biol. 80 (1998) 209-214
41. Ishikawa H., Nakanishi T., Inoue T., and Kuzuya K. Prognostic factors of adenocarcinoma of the uterine cervix. Gynecol. Oncol. 73 (1999) 42-46
42. Potosky A.L., Riley G.F., Lubitz J.D., Mentnech R.M., and Kessler L.G. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med. Care 31 (1993) 732-748
43. Warren J.L., Klabunde C.N., Schrag D., Bach P.B., and Riley G.F. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med. Care 40 8 Suppl. (2002) 3-18
44. Ries L.A.G., Eisner M.P., Kosary C.L., Hankey B.F., Miller B.A., Clegg L., et al. SEER cancer statistics review, 1975-2000 (2003), National Cancer Institute, Bethesda, MD
45. Rajaram S.S. Non-adherence to follow-up treatment of an abnormal Pap smear: a case study. Cancer Nurs. 21 (1998) 342-348
46. Krieger N., Chen J.T., Waterman P.D., Soobader M.-J., Subramanian S.V., and Carsos R. Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does choice of area-based measure and geographic level matter? The Public Health Disparities Geocoding Project. Am. J. Epidemiol. 156 (2002) 471-482
47. Summary File 3. Census 2000. In: U.S. Census Bureau.; 2000.
48. Du X.L., Chan W., Giordano S., Geraci J.M., Delclos G.L., Burau K., et al. Variation in modes of chemotherapy administration for breast carcinoma and association with hospitalization for chemotherapy-related toxicity. Cancer 104 5 (2005) 913-924
49. Klabunde C.N., Potosky A.L., Legler J.M., and Warren J.L. Development of a comorbidity index using physician claims data. J. Clin. Epidemiol. 53 (2000) 1258-1267
50. Charlson M.E., Pompei P., Ales K.L., et al. A new methods of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic. Dis. 40 (1987) 373-383
51. Deyo R.A., Cherkin D.C., and Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J. Clin. Epidemiol. 45 (1992) 613-619
52. Romano P.S., Roos L.L., and Jollis J.G. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J. Clin. Epidemiol. 46 (1993) 1075-1079
53. The SEER Program Code Manual. Bethesda, MD: National Cancer Institute; 1994. Report No.: NIH Publication No. 94-1999.
54. Du X.L., Freeman J.L., and Goodwin J.S. Information on radiation treatment in patients with breast cancer: the advantages of the linked Medicare and SEER data. J. Clin. Epidemiol. 52 (1999) 463-470
55. Du X.L., and Goodwin J.S. Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data. J. Clin. Oncol. 19 (2001) 1455-1461
56. Du X.L., and Goodwin J.S. Increase of chemotherapy use in older women with breast carcinoma from 1991 to 1996. Cancer 92 (2001) 730-737
57. Du X.L., Osborne C., and Goodwin J.S. Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer. J. Clin. Oncol. 20 (2002) 4636-4642
58. Trimble E.L., Harlan L.C., and Clegg L.X. Untreated cervical cancer in the United States. Gynecol. Oncol. 96 (2005) 271-277
59. Krane J.F., Granter S.R., Trask C.E., et al. Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix: a study of 49 cases. Cancer 93 (2001) 8-15
60. Renshaw A.A., Mody D.R., Lozano R.L., Volk E.E., Walsh M.K., Davey D.D., et al. Detection of adenocarcinoma in situ of the cervix in Papanicolaou tests: comparison of diagnostic accuracy with other high-grade lesions. Arch. Pathol. Lab. Med. 128 (2004) 153-157
61. Mitchell J.B.P., and McCormack L.A. Time trends in late-stage diagnosis of cervical cancer: differences by race/ethnicity and income. Med. Care 35 (1997) 1220-1224